![](https://biowin.org/wp-content/uploads/2022/05/Investor-Perspective-Plasma-screens.png)
WEBINAR
Investor Perspective: The Strategic Venturing Spectrum
June 7, 2022 | Virtual
16:00 – 17:00 CEST
ORGANIZED BY JOHNSON & JOHNSON INNOVATION
Is your startup interested in access to Corporate Venture Capital (CVC)? You may be more successful in landing an investment if you learn to look from their perspective. What’s in it for them?
For CVCs financial returns on investments are usually only part of the equation. Large corporations can use investments as a vehicle to get early access to new innovations. They strategically look for companies developing assets and technologies that might complement their pipeline in the future.
So how do CVCs maximize the value for their company with a balance between capital and strategic objectives? How do they measure their success? They may invest early or late. They may invest close to the core business to sustain incremental innovation or ahead of business into peripheral and/or disruptive innovation.
They may work independent from their mother company or work closely with the business units. By following a portfolio approach, a CVC might actually be doing all of that at the same time.
Join the discussion during this Johnson & Johnson Innovation webinar as we explore the spectrum of strategic venturing. During the panel investors from CVCs with different approaches share insights focusing on the biotech ecosystem.